CSF1R and melanoma: In addition, the combination of colony stimulating factor 1 receptor (CSF1R) inhibitor with anti-PD-L1/PD-1 axis blockage has been reported to be highly active in both melanoma and hepatocellular carcinoma mouse models by elimination of tumor-associated macrophages (TAMs)40,41.